ArticleInternational journal of cancer2014

Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts.

Alexandre Ingels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.